150 related articles for article (PubMed ID: 16611122)
1. Current status of anti-picornavirus therapies.
Barnard DL
Curr Pharm Des; 2006; 12(11):1379-90. PubMed ID: 16611122
[TBL] [Abstract][Full Text] [Related]
2. Antiviral agents against picornaviruses.
Eggers HJ
Antiviral Res; 1985; Suppl 1():57-65. PubMed ID: 3002267
[No Abstract] [Full Text] [Related]
3. Selective inhibitors of picornavirus replication.
De Palma AM; Vliegen I; De Clercq E; Neyts J
Med Res Rev; 2008 Nov; 28(6):823-84. PubMed ID: 18381747
[TBL] [Abstract][Full Text] [Related]
4. Antiviral therapy for enteroviruses and rhinoviruses.
Rotbart HA
Antivir Chem Chemother; 2000 Jul; 11(4):261-71. PubMed ID: 10950388
[TBL] [Abstract][Full Text] [Related]
5. Treatment of picornavirus infections.
Rotbart HA
Antiviral Res; 2002 Feb; 53(2):83-98. PubMed ID: 11750935
[TBL] [Abstract][Full Text] [Related]
6. Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and anti-picornavirus drug discovery.
Ramajayam R; Tan KP; Liang PH
Biochem Soc Trans; 2011 Oct; 39(5):1371-5. PubMed ID: 21936817
[TBL] [Abstract][Full Text] [Related]
7. Direct-acting antivirals and host-targeting strategies to combat enterovirus infections.
Bauer L; Lyoo H; van der Schaar HM; Strating JR; van Kuppeveld FJ
Curr Opin Virol; 2017 Jun; 24():1-8. PubMed ID: 28411509
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent antipicornavirus activity.
Barnard DL; Hubbard VD; Smee DF; Sidwell RW; Watson KG; Tucker SP; Reece PA
Antimicrob Agents Chemother; 2004 May; 48(5):1766-72. PubMed ID: 15105133
[TBL] [Abstract][Full Text] [Related]
9. Combating enterovirus replication: state-of-the-art on antiviral research.
Thibaut HJ; De Palma AM; Neyts J
Biochem Pharmacol; 2012 Jan; 83(2):185-92. PubMed ID: 21889497
[TBL] [Abstract][Full Text] [Related]
10. Picornavirus inhibitors.
Carrasco L
Pharmacol Ther; 1994; 64(2):215-90. PubMed ID: 7533301
[TBL] [Abstract][Full Text] [Related]
11. Picornavirus infections: a primer for the practitioner.
Rotbart HA; Hayden FG
Arch Fam Med; 2000; 9(9):913-20. PubMed ID: 11031400
[TBL] [Abstract][Full Text] [Related]
12. Progress in human picornavirus research: New findings from the AIROPico consortium.
Wolthers KC; Susi P; Jochmans D; Koskinen J; Landt O; Sanchez N; Palm K; Neyts J; Butcher SJ
Antiviral Res; 2019 Jan; 161():100-107. PubMed ID: 30472162
[TBL] [Abstract][Full Text] [Related]
13. Picornavirus non-structural proteins as targets for new anti-virals with broad activity.
Norder H; De Palma AM; Selisko B; Costenaro L; Papageorgiou N; Arnan C; Coutard B; Lantez V; De Lamballerie X; Baronti C; Solà M; Tan J; Neyts J; Canard B; Coll M; Gorbalenya AE; Hilgenfeld R
Antiviral Res; 2011 Mar; 89(3):204-18. PubMed ID: 21236302
[TBL] [Abstract][Full Text] [Related]
14. Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections.
Wang QM
Prog Drug Res; 2001; Spec No():229-53. PubMed ID: 11548209
[TBL] [Abstract][Full Text] [Related]
15. Exploration of the anti-enterovirus activity of a series of pleconaril/pirodavir-like compounds.
Bernard A; Lacroix C; Cabiddu MG; Neyts J; Leyssen P; Pompei R
Antivir Chem Chemother; 2015 Apr; 24(2):56-61. PubMed ID: 26071135
[TBL] [Abstract][Full Text] [Related]
16. Enterovirus infections with special reference to enterovirus 71.
Hsiung GD; Wang JR
J Microbiol Immunol Infect; 2000 Mar; 33(1):1-8. PubMed ID: 10806956
[TBL] [Abstract][Full Text] [Related]
17. Picornavirus and enterovirus diversity with associated human diseases.
Tapparel C; Siegrist F; Petty TJ; Kaiser L
Infect Genet Evol; 2013 Mar; 14():282-93. PubMed ID: 23201849
[TBL] [Abstract][Full Text] [Related]
18. The enteroviruses: problems in need of treatments.
Abzug MJ
J Infect; 2014 Jan; 68 Suppl 1():S108-14. PubMed ID: 24119825
[TBL] [Abstract][Full Text] [Related]
19. The Picornaviridae Family: Knowledge Gaps, Animal Models, Countermeasures, and Prototype Pathogens.
Andino R; Kirkegaard K; Macadam A; Racaniello VR; Rosenfeld AB
J Infect Dis; 2023 Oct; 228(Suppl 6):S427-S445. PubMed ID: 37849401
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials.
Hayden FG; Herrington DT; Coats TL; Kim K; Cooper EC; Villano SA; Liu S; Hudson S; Pevear DC; Collett M; McKinlay M;
Clin Infect Dis; 2003 Jun; 36(12):1523-32. PubMed ID: 12802751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
